Revere Hotel, Boston, MA
August 22-23, 2018
East River BioSolutions is excited to exhibit at the upcoming PREDiCT: 3D Models Summit in Boston. Please join us to learn more about our innovative 3D cell culture products and services. We look forward to seeing you at our booth!
July 1, 2018
Brooklyn, New York
We are pleased to announce that East River BioSolutions has expanded and moved to a new location at the SUNY Downstate Advanced Biotechnology Incubator in Brooklyn, New York. Our new address is 760 Parkside Avenue, Brooklyn, New York 11226.
Since 2016, the Alexandria Center for Life Science, and especially Alexandria LaunchLabs, provided East River Bio a home – a central location, interactive life science campus, shared resources, access to new customers and partners, and an outstanding community of scientists and entrepreneurs. As our sales and team continued to grow, we were in need of a larger space to accommodate our team and a significantly expanded production facility.
Our expansion into Brooklyn represents an exciting new chapter in East River Bio’s story, and we look forward to continued successes as we scale and diversify our R&D and production efforts. Feel free to stop by and say ‘hi’ if you’re in the area!
The Westin Copley Place, Boston, MA
June 18-21, 2018
East River BioSolutions is excited to exhibit at the upcoming World Preclinical Congress in Boston. Please join us at booth #208 to learn more about our innovative products and services. We look forward to seeing you at our booth!
We would like to congratulate our Chair of the Board, Gordana Vunjak-Novakovic, for her appointment to the rank of University Professor, Columbia’s highest academic honor!
Read full story here.
On April 25th 2017, MatriTek revealed its new name: East River BioSolutions.
The broader, more encompassing name better captures the company’s vision of revolutionizing the biomedical research and regenerative medicine markets.
“We have an exceptional track record of engineering and scientific excellence and are at the forefront of unlocking the power of native tissue matrix to develop innovative solutions to serve the life sciences industry. Going forward as East River BioSolutions, we will leverage that expertise to provide a wider range of cutting edge products,” commented Andrea Nye, CEO of East River BioSolutions.
East River BioSolutions will continue to strengthen its leading portfolio of tissue-specific extracellular matrices, complementing it with new offerings such as tissue-specific bio-inks and expanding application of its technologies in the growing therapeutic and biomedical markets.
Boston Convention and Exhibition Center, Boston, MA
June 14-17, 2017
East River BioSolutions is excited to exhibit at the upcoming ISSCR annual meeting in Boston. Please join us at booth #110 to learn more about our innovative products and services. We look forward to seeing you at our booth!
San Diego Convention Center, 111 W Harbor Dr., San Diego, CA
June 19-23, 2017
East River BioSolutions is looking forward to exhibiting during the BIO International Convention in San Diego. Please join us at booth #5222 to learn more about our TissueSpec™ biomaterials. We look forward to seeing you at our booth!
Manchester Grand Hyatt, San Diego, CA
December 11-14, 2016
MatriTek is excited to announce that we will present our novel Tissue-Specific Extracellular Matrix Biomaterials during TERMIS-AM Meeting in San Diego. Please join us at booth No 105 to learn how our products drive innovation and enable new scientific discoveries. We can’t wait to see you at our booth!
Hynes Convention Center, Boston, Massachusetts.
November 29 – December 1, 2016.
MatriTek is excited to announce that we will present our novel Tissue-Specific Extracellular Matrix Biomaterials during the MRS Fall Meeting in Boston. Please join us at booth No. 1208 to learn about our products and services.
New York, September 28, 2016: MatriTek, Inc., a product-oriented biotechnology company specializing in tissue-specific cell culture biomaterials, announced today the launch of commercial production of novel extracellular matrix (ECM) biomaterials for biomedical research.